Trial Condition(s):
Pregnancy
Duration of use of highly effective reversible contraception
Bayer Identifier:
17714
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
To assess the proportion of women who use HERC for ≥2 years of duration
Inclusion Criteria
: -Women who had an IUD or contraceptive implant inserted and removed within the University of Utah from January 1, 2004 to October 31, 2012
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
13880
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteers
No
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Investigative Site Salt Lake, United States | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Real-world duration of use for highly effective reversible contraception (HERC): A retrospective review
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Proportion of women who use HERCTimeframe: 2 years post-HERC initiation
Secondary Outcome
- Duration of real world use of three different HERC devicesTimeframe: 2 years post-HERC initiation
Additional Information
Copyright © Bayer
Powered by
